Literature DB >> 25593076

The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria.

Jacques Galipeau1, Mauro Krampera2.   

Abstract

Mesh：

Year:  2015        PMID： 25593076     DOI： 10.1016/j.jcyt.2014.12.008

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


× No keyword cloud information.
  27 in total

1.  Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.

Authors:  Bahey Salem; Samantha Miner; Nancy F Hensel; Minoo Battiwalla; Keyvan Keyvanfar; David F Stroncek; Adrian P Gee; Patrick J Hanley; Catherine M Bollard; Sawa Ito; A John Barrett
Journal:  Cytotherapy       Date:  2015-09-28       Impact factor: 5.414

2.  Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming.

Authors:  Raghavan Chinnadurai; Devi Rajan; Spencer Ng; Kenneth McCullough; Dalia Arafat; Edmund K Waller; Larry J Anderson; Greg Gibson; Jacques Galipeau
Journal:  Blood Adv       Date:  2017-04-25

Review 3.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

4.  Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical Approach.

Authors:  Raghavan Chinnadurai; Augustine Rajakumar; Andrew J Schneider; Wade A Bushman; Peiman Hematti; Jacques Galipeau
Journal:  Stem Cells       Date:  2019-06-03       Impact factor: 6.277

5.  Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity.

Authors:  Matthew W Klinker; Ross A Marklein; Jessica L Lo Surdo; Cheng-Hong Wei; Steven R Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-10       Impact factor: 11.205

Review 6.  Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disorders.

Authors:  Won Soon Park; So Yoon Ahn; Se In Sung; Jee-Yin Ahn; Yun Sil Chang
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

7.  Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

Authors:  Raghavan Chinnadurai; Devi Rajan; Muna Qayed; Dalia Arafat; Marco Garcia; Yifei Liu; Subra Kugathasan; Larry J Anderson; Greg Gibson; Jacques Galipeau
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

8.  Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.

Authors:  Raghavan Chinnadurai; Ian B Copland; Marco A Garcia; Christopher T Petersen; Christopher N Lewis; Edmund K Waller; Allan D Kirk; Jacques Galipeau
Journal:  Stem Cells       Date:  2016-07-04       Impact factor: 6.277

Review 9.  Intra-articular treatment options for knee osteoarthritis.

Authors:  Ian A Jones; Ryan Togashi; Melissa L Wilson; Nathanael Heckmann; C Thomas Vangsness
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

10.  International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Authors:  Jacques Galipeau; Mauro Krampera; John Barrett; Francesco Dazzi; Robert J Deans; Joost DeBruijn; Massimo Dominici; Willem E Fibbe; Adrian P Gee; Jeffery M Gimble; Peiman Hematti; Mickey B C Koh; Katarina LeBlanc; Ivan Martin; Ian K McNiece; Michael Mendicino; Steve Oh; Luis Ortiz; Donald G Phinney; Valerie Planat; Yufang Shi; David F Stroncek; Sowmya Viswanathan; Daniel J Weiss; Luc Sensebe
Journal:  Cytotherapy       Date:  2015-12-23       Impact factor: 5.414
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.